Our results demonstrate that NHD13 mice exhibits anemia, increased serum erythropoietin (EPO), expanded erythropoiesis in the bone marrow and spleen, and parenchymal iron overload, consistent with a low-risk MDS phenotype in patients. The gene discussed is EPO; the disease is myelodysplastic syndrome.